As professionals of cardiovascular biology and medicine, we not only provide the world's highest level of medical care based on cutting-edge knowledge and insight but are also pursuing research in fields that are original and advanced, with high potential for realization. At the same time, we are also nurturing world-class human resources who will pioneer the future of cardiovascular biology and medicine.
Coronary Artery Diseases (Imaging / Doi Team)
With state-of-the-art intravascular imaging technology, the challenge ranging from understanding and shedding light on pathological conditions to developing treatment strategies is being undertaken.
Coronary Artery Diseases (Pathological mechanism, Iwata Team)
Embarking on a quest for science to prevent arteriosclerosis
Predicting the therapeutic effects of cerebral infarction / bleeding events and catheter ablation of atrial fibrillation and providing appropriate medical care.
Heart Failure / Cardiomyopathy Group
Multi-facility clinical research and work on implementing precision medicine in the field of heart failure.
Sleep Apnea Group
Therapeutic intervention for sleep apnea syndrome, thereby paving the way for cardiovascular disease improvement.
Cardiovascular Imaging Group
Supporting further developments in the cardiovascular imaging field with new image analysis technologies.
Using echocardiography for early detection of cardiac dysfunction in cancer patients caused by anticancer drugs
Pulmonary Hypertension Group
Establishing treatment guidelines for pulmonary hypertension and undertaking research projects that contribute to the medical economy
Cardiac Rehabilitation Group
Developing a scientific “cardiac rehabilitation" program that will be the key to preventing cardiovascular diseases
Aging Control Research Group
Working on creating next-generation cardiovascular disease treatment through aging control
Inflammatory Immunoregulation / Vascular Biology Group
Taking on the challenge of searching for new anti-inflammatory treatments that will lead to the prevention of cardiovascular diseases
Molecular Heart Failure Research Group
Endeavoring to establish preemptive medical care for age-related diseases such as heart failure without being bound by stereotypical views